BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23395922)

  • 1. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers.
    Jelliffe-Pawlowski LL; Shaw GM; Currier RJ; Stevenson DK; Baer RJ; O'Brodovich HM; Gould JB
    Am J Obstet Gynecol; 2013 Jun; 208(6):492.e1-11. PubMed ID: 23395922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.
    Jelliffe-Pawlowski LL; Baer RJ; Blumenfeld YJ; Ryckman KK; O'Brodovich HM; Gould JB; Druzin ML; El-Sayed YY; Lyell DJ; Stevenson DK; Shaw GM; Currier RJ
    BJOG; 2015 Oct; 122(11):1484-93. PubMed ID: 26111589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester serum biomarker screening for fetal Down syndrome as a predictor of preterm delivery: a population-based study.
    Pornwattanakrilert W; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1717-1724. PubMed ID: 30371129
    [No Abstract]   [Full Text] [Related]  

  • 4. First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption.
    Ananth CV; Wapner RJ; Ananth S; D'Alton ME; Vintzileos AM
    Obstet Gynecol; 2017 Mar; 129(3):465-472. PubMed ID: 28178056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based biomarker screening and the development of severe preeclampsia in California.
    Taché V; Baer RJ; Currier RJ; Li CS; Towner D; Waetjen LE; Jelliffe-Pawlowski LL
    Am J Obstet Gynecol; 2014 Oct; 211(4):377.e1-8. PubMed ID: 24631701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
    Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Biochemical Analytes Used for Aneuploidy Screening and Adverse Pregnancy Outcomes in Twin Gestations.
    Rosner JY; Fox NS; Saltzman D; Klauser CK; Rebarber A; Gupta S
    Am J Perinatol; 2015 Dec; 32(14):1331-5. PubMed ID: 26375045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
    Nunthapiwat S; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    Gynecol Obstet Invest; 2019; 84(4):326-333. PubMed ID: 30602167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption.
    Blumenfeld YJ; Baer RJ; Druzin ML; El-Sayed YY; Lyell DJ; Faucett AM; Shaw GM; Currier RJ; Jelliffe-Pawlowski LL
    Am J Obstet Gynecol; 2014 Aug; 211(2):144.e1-9. PubMed ID: 24631707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined elevated midpregnancy tumor necrosis factor alpha and hyperlipidemia in pregnancies resulting in early preterm birth.
    Jelliffe-Pawlowski LL; Ryckman KK; Bedell B; O'Brodovich HM; Gould JB; Lyell DJ; Borowski KS; Shaw GM; Murray JC; Stevenson DK
    Am J Obstet Gynecol; 2014 Aug; 211(2):141.e1-9. PubMed ID: 24831886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies.
    Jelliffe-Pawlowski LL; Baer RJ; Currier RJ
    Prenat Diagn; 2010 Aug; 30(8):727-33. PubMed ID: 20661885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations.
    McLean M; Bisits A; Davies J; Walters W; Hackshaw A; De Voss K; Smith R
    Am J Obstet Gynecol; 1999 Jul; 181(1):207-15. PubMed ID: 10411821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies.
    Dane B; Dane C; Batmaz G; Ates S; Dansuk R
    Gynecol Endocrinol; 2013 Jun; 29(6):592-5. PubMed ID: 23656388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA fetal fraction and preterm birth.
    Dugoff L; Barberio A; Whittaker PG; Schwartz N; Sehdev H; Bastek JA
    Am J Obstet Gynecol; 2016 Aug; 215(2):231.e1-7. PubMed ID: 26875947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Br J Obstet Gynaecol; 1997 Jul; 104(7):811-7. PubMed ID: 9236646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory biomarkers and spontaneous preterm birth among obese women.
    Wallenstein MB; Jelliffe-Pawlowski LL; Yang W; Carmichael SL; Stevenson DK; Ryckman KK; Shaw GM
    J Matern Fetal Neonatal Med; 2016 Oct; 29(20):3317-22. PubMed ID: 26700828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
    Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of first-trimester pregnancy-associated plasma protein A levels and idiopathic preterm delivery: A population-based screening study.
    Pummara P; Tongsong T; Wanapirak C; Sirichotiyakul S; Luewan S
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):72-5. PubMed ID: 26927253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.